Samsara revenue and financials
In the fiscal year ended January 2026, Samsara reported revenue of $1.62B (+29.57% year over year). The net loss was $9.12M.
Fiscal year ending in January. Sources and method on the page How we analyse stocks.
At a glance
- Revenue growth
- +29.57%
- FY to Jan 2026 vs FY to Jan 2025
- Net margin
- -0.6%
- FY to Jan 2025: -12.4%
How Samsara is changing
Calculated from the annual statements; each fiscal year is labelled with the year it ends.
Revenue grew 45.3% a year on average over the last 5 years
Compound annual growth rate: from $249.91M in 2021 to $1.62B in 2026.
Revenue has grown for 6 fiscal years in a row
Each fiscal year compared with the one before, up to 2026.
Operating margin rose from −39.6% to −3.2%
Operating income over revenue, 2023 → 2026: 36.4 percentage points.
Shares outstanding up 139.7% in 5 years
Average diluted shares, 2021 → 2026: with more shares, each one represents a smaller stake in the company (dilution).
Profitable in 0 of 5 fiscal years
Positive net income, fiscal years 2022–2026.
Financial data
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jan 2026 | FY to Jan 2025 | FY to Jan 2024 | FY to Jan 2023 | FY to Jan 2022 | FY to Jan 2021 | FY to Jan 2020 |
|---|---|---|---|---|---|---|---|
| Total revenue | 1,619 | 1,249 | 937 | 653 | 428 | 250 | 120 |
| Cost of revenue | 376 | 297 | 246 | 182 | 124 | 75.4 | 48.3 |
| Gross profit | 1,243 | 952 | 691 | 470 | 304 | 175 | 71.5 |
| Selling, general and administrative | 950 | 836 | 682 | 541 | 451 | 277 | 229 |
| Research and development | 345 | 300 | 259 | 187 | 205 | 99.7 | 70.5 |
| Operating income | -52.6 | -185 | -250 | -258 | -352 | -203 | -228 |
| EBIT | -52.6 | -185 | -250 | -258 | -352 | -203 | -228 |
| EBITDA | -42.6 | -173 | -239 | -251 | -345 | -195 | -226 |
| Pre-tax income | 0.9 | -150 | -283 | -244 | -354 | -210 | -225 |
| Income tax | 10.0 | 4.5 | 3.3 | 3.6 | 1.2 | 0.1 | 0.3 |
| Net income | -9.1 | -155 | -287 | -247 | -355 | -210 | -225 |
| Net income to common shareholders | -9.1 | -155 | -287 | -247 | -355 | -220 | -225 |
| Basic EPS | -0.02 | -0.28 | -0.54 | -0.48 | -1.28 | -0.92 | -0.98 |
| Diluted EPS | -0.02 | -0.28 | -0.54 | -0.48 | -1.28 | -0.92 | -0.98 |
| Average shares (basic) | 573 | 556 | 535 | 514 | 278 | 239 | 230 |
| Average shares (diluted) | 573 | 556 | 535 | 514 | 278 | 239 | 230 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q to Jul 2026 | Q to Apr 2026 | Q to Jan 2026 | Q to Oct 2025 | Q to Jul 2025 | Q to Apr 2025 | Q to Jan 2025 | Q to Oct 2024 | Q to Jul 2024 | Q to Apr 2024 | Q to Jan 2024 | Q to Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 508 | 479 | 444 | 416 | 391 | 367 | 346 | 322 | 300 | 281 | 276 | 238 |
| Cost of revenue | 116 | 117 | 105 | 96.8 | 90.2 | 82.8 | 79.3 | 75.7 | 73.2 | 68.2 | 68.2 | 61.4 |
| Gross profit | 393 | 361 | 339 | 319 | 301 | 284 | 267 | 246 | 227 | 213 | 208 | 176 |
| Selling, general and administrative | 285 | 256 | 240 | 235 | 242 | 234 | 210 | 213 | 209 | 205 | 188 | 165 |
| Research and development | 103 | 97.6 | 89.5 | 86.2 | 85.6 | 83.2 | 73.3 | 77.0 | 76.5 | 73.0 | 73.4 | 60.8 |
| Operating income | 4.9 | 7.2 | 9.0 | -1.7 | -26.6 | -33.3 | -17.1 | -43.8 | -58.2 | -66.0 | -54.3 | -50.0 |
| EBIT | 4.9 | 7.2 | 9.0 | -1.7 | -26.6 | -33.3 | -17.1 | -43.8 | -58.2 | -66.0 | -54.3 | -50.0 |
| EBITDA | 8.2 | 10.2 | 12.4 | 0.7 | -24.5 | -31.1 | -14.9 | -39.4 | -55.7 | -63.4 | -51.1 | -46.4 |
| Pre-tax income | 17.5 | 48.9 | 27.5 | 9.1 | -15.2 | -20.5 | -8.6 | -37.3 | -48.6 | -55.9 | -112 | -45.4 |
| Income tax | 1.3 | 4.4 | 5.5 | 1.3 | 1.6 | 1.6 | 2.6 | 0.5 | 1.0 | 0.4 | 1.8 | 0.1 |
| Net income | 16.2 | 44.5 | 22.0 | 7.8 | -16.8 | -22.1 | -11.2 | -37.8 | -49.6 | -56.3 | -113 | -45.5 |
| Net income to common shareholders | 16.2 | 44.5 | 22.0 | 7.8 | -16.8 | -22.1 | -11.2 | -37.8 | -49.6 | -56.3 | -113 | -45.5 |
| Basic EPS | 0.03 | 0.08 | 0.04 | 0.01 | -0.03 | -0.04 | -0.02 | -0.07 | -0.09 | -0.10 | -0.21 | -0.08 |
| Diluted EPS | 0.03 | 0.08 | 0.03 | 0.01 | -0.03 | -0.04 | -0.02 | -0.07 | -0.09 | -0.10 | -0.21 | -0.08 |
| Average shares (basic) | 584 | 582 | 579 | 575 | 572 | 568 | 564 | 559 | 554 | 549 | 543 | 537 |
| Average shares (diluted) | 590 | 588 | 588 | 586 | 572 | 568 | 564 | 559 | 554 | 549 | 543 | 537 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jan 2026 | FY to Jan 2025 | FY to Jan 2024 | FY to Jan 2023 | FY to Jan 2022 | FY to Jan 2021 | FY to Jan 2020 |
|---|---|---|---|---|---|---|---|
| Total assets | 2,541 | 2,024 | 1,735 | 1,617 | 1,568 | 887 | 631 |
| Current assets | 1,507 | 1,212 | 887 | 958 | 1,100 | 491 | 277 |
| Cash and equivalents | 319 | 228 | 136 | 201 | 921 | 400 | 201 |
| Short-term investments | 515 | 467 | 412 | 489 | — | — | — |
| Receivables | 328 | 240 | 167 | 123 | 82.0 | 42.2 | 34.2 |
| Inventory | 48.2 | 38.9 | 22.2 | 40.6 | 33.1 | 13.7 | 16.5 |
| Net property, plant and equipment | 142 | 123 | 137 | 163 | 164 | 186 | 200 |
| Other intangible assets | — | — | — | 8.7 | 6.7 | 5.0 | 2.6 |
| Long-term investments | 403 | 283 | 276 | 113 | — | — | — |
| Current liabilities | 917 | 761 | 592 | 442 | 338 | 212 | 148 |
| Accounts payable | 47.7 | 64.0 | 46.3 | 30.1 | 54.7 | 19.4 | 16.5 |
| Total debt | 72.8 | 80.3 | 99.5 | 123 | 145 | 173 | 184 |
| Total liabilities | 1,120 | 955 | 820 | 679 | 579 | 470 | 432 |
| Total equity (incl. minority) | 1,420 | 1,069 | 915 | 938 | 989 | 416 | 199 |
| Retained earnings | -1,619 | -1,610 | -1,455 | -1,168 | -921 | -566 | -346 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q to Jul 2026 | Q to Apr 2026 | Q to Jan 2026 | Q to Oct 2025 | Q to Jul 2025 | Q to Apr 2025 | Q to Jan 2025 | Q to Oct 2024 | Q to Jul 2024 | Q to Apr 2024 | Q to Jan 2024 | Q to Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2,769 | 2,614 | 2,541 | 2,314 | 2,207 | 2,074 | 2,024 | 1,864 | 1,826 | 1,749 | 1,735 | 1,686 |
| Current assets | 1,573 | 1,478 | 1,507 | 1,258 | 1,186 | 1,133 | 1,212 | 1,039 | 1,040 | 924 | 887 | 941 |
| Cash and equivalents | 291 | 219 | 319 | 275 | 258 | 259 | 228 | 160 | 159 | 162 | 136 | 208 |
| Short-term investments | 538 | 585 | 515 | 487 | 443 | 439 | 467 | 512 | 513 | 432 | 412 | 452 |
| Receivables | 346 | 292 | 328 | 263 | 253 | 223 | 240 | 184 | 184 | 149 | 167 | 119 |
| Inventory | 57.0 | 52.2 | 48.2 | 55.0 | 47.6 | 37.9 | 38.9 | 39.4 | 38.6 | 30.5 | 22.2 | 27.1 |
| Net property, plant and equipment | 146 | 142 | 142 | 141 | 134 | 130 | 123 | 126 | 130 | 133 | 137 | 129 |
| Other intangible assets | — | — | — | — | — | — | — | — | — | — | — | 13.0 |
| Long-term investments | 497 | 477 | 403 | 385 | 386 | 325 | 283 | 241 | 208 | 251 | 276 | 189 |
| Current liabilities | 968 | 912 | 917 | 806 | 792 | 741 | 761 | 654 | 647 | 601 | 592 | 506 |
| Accounts payable | 41.2 | 24.3 | 47.7 | 19.8 | 30.1 | 22.3 | 64.0 | 31.5 | 47.3 | 41.2 | 46.3 | 38.3 |
| Total debt | 69.5 | 69.0 | 72.8 | 75.6 | 77.2 | 82.1 | 80.3 | 86.0 | 87.7 | 93.6 | — | — |
| Total liabilities | 1,167 | 1,106 | 1,120 | 1,010 | 992 | 946 | 955 | 865 | 861 | 826 | 820 | 735 |
| Total equity (incl. minority) | 1,602 | 1,508 | 1,420 | 1,303 | 1,215 | 1,128 | 1,069 | 999 | 965 | 924 | 915 | 951 |
| Retained earnings | -1,558 | -1,575 | -1,619 | -1,641 | -1,649 | -1,632 | -1,610 | -1,599 | -1,561 | -1,511 | -1,455 | -1,342 |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | FY to Jan 2026 | FY to Jan 2025 | FY to Jan 2024 | FY to Jan 2023 | FY to Jan 2022 | FY to Jan 2021 | FY to Jan 2020 |
|---|---|---|---|---|---|---|---|
| Operating cash flow | 236 | 132 | -11.8 | -103 | -171 | -172 | -193 |
| Depreciation and amortization | 9.9 | 11.6 | 10.7 | 7.9 | 7.1 | 7.9 | 2.3 |
| Capital expenditure | -28.8 | -20.2 | -11.0 | -33.2 | -19.4 | -32.1 | -30.0 |
| Investing cash flow | -190 | -66.6 | -78.7 | -632 | -20.0 | -32.2 | -30.0 |
| Financing cash flow | 29.9 | 27.1 | 21.0 | 14.2 | 702 | 402 | 296 |
| Share repurchases | — | — | 0.0 | 0.0 | -142 | -0.1 | -0.0 |
| Debt repaid | — | — | — | -1.3 | -0.5 | -0.2 | — |
| Effect of exchange rates | 2.4 | -1.1 | 0.5 | 0.1 | -0.1 | — | — |
| Net change in cash | 79.0 | 91.1 | -69.0 | -721 | 510 | 198 | 73.3 |
| Free cash flow | 207 | 111 | -22.8 | -136 | -191 | — | — |
| Levered free cash flow | 284 | 161 | 165 | 9.1 | 48.6 | -78.5 | — |
Amounts in millions of USD; per-share values in USD; shares in millions.
| Item | Q to Jul 2026 | Q to Apr 2026 | Q to Jan 2026 | Q to Oct 2025 | Q to Jul 2025 | Q to Apr 2025 | Q to Jan 2025 | Q to Oct 2024 | Q to Jul 2024 | Q to Apr 2024 | Q to Jan 2024 | Q to Oct 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 73.5 | 81.4 | 69.7 | 63.7 | 50.2 | 52.6 | 53.9 | 36.0 | 18.1 | 23.7 | -41.9 | 11.9 |
| Depreciation and amortization | 3.3 | 3.0 | 3.3 | 2.4 | 2.1 | 2.1 | 2.2 | 4.4 | 2.5 | 2.6 | -0.1 | 3.6 |
| Capital expenditure | -8.8 | -8.2 | -8.0 | -7.9 | -6.0 | -6.9 | -5.3 | -4.8 | -5.0 | -5.1 | -2.1 | -3.4 |
| Investing cash flow | 19.7 | -149 | -54.8 | -48.3 | -68.2 | -18.3 | 0.5 | -33.9 | -36.3 | 3.1 | -42.6 | -1.5 |
| Financing cash flow | -19.0 | -34.4 | 12.0 | -0.1 | 18.4 | -0.4 | 11.5 | -0.4 | 15.7 | 0.3 | 9.0 | -0.2 |
| Share repurchases | -36.0 | -34.3 | — | — | — | — | — | — | — | — | — | — |
| Debt repaid | — | — | — | 0.7 | — | — | — | 0.9 | -0.4 | -0.5 | -0.8 | -0.5 |
| Effect of exchange rates | -1.9 | -0.4 | 1.5 | -0.4 | 0.2 | 1.1 | -0.6 | 0.1 | -0.5 | -0.1 | 0.5 | -0.5 |
| Net change in cash | 72.3 | -103 | 28.5 | 14.9 | 0.6 | 35.1 | 65.2 | 1.9 | -3.0 | 26.9 | -75.0 | 9.7 |
| Free cash flow | 64.7 | 73.2 | 61.7 | 55.8 | 44.2 | 45.7 | 48.5 | 31.2 | 13.1 | 18.6 | -44.0 | 8.5 |
| Levered free cash flow | 86.1 | 77.9 | 21.4 | 77.8 | 67.1 | 119 | 19.6 | 55.1 | 44.3 | 42.8 | 60.3 | 23.9 |
Financial statements of similar companies
Companies in the group: same industry, similar size
